denkapparat Operations’s BioMarin Pharmaceuticals BMRN Stock Holding History

denkapparat Operations’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$683K	Hold	11,938	–	–	0.22%	184
2026 Q1	$674K	Sell	11,938 -1,886	-14%	-$110K	0.28%	138
2025 Q4	$822K	Buy	13,824 +2,756	+25%	+$150K	0.45%	77
2025 Q3	$599K	Buy	11,068 +3,442	+45%	+$197K	0.38%	98
2025 Q2	$419K	Buy	7,626 +500	+7%	+$29.4K	0.33%	120
2025 Q1	$504K	Buy	+7,126	New	+$479K	0.53%	67

Other funds holding BMRN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

denkapparat Operations's BMRN Position: Q2 2026 in Review

denkapparat Operations held its BioMarin Pharmaceuticals (BMRN) position steady in Q2 2026 at 11,938 shares worth $683K. The position accounts for 0.22% of the portfolio, ranked #184.

denkapparat Operations first reported a position in BMRN in Q1 2025 and has held it in 6 quarters since. The position peaked at $822K in Q4 2025. 565 funds tracked by Wall St. Rank hold BMRN as of Q2 2026.

denkapparat Operations held 11,938 shares of BioMarin Pharmaceuticals worth $683K as of Q2 2026.
denkapparat Operations left its BioMarin Pharmaceuticals share count unchanged in Q2 2026.
BioMarin Pharmaceuticals made up 0.22% of denkapparat Operations's portfolio in Q2 2026, its #184 holding.
denkapparat Operations first reported a position in BioMarin Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
denkapparat Operations's BioMarin Pharmaceuticals position peaked at $822K in Q4 2025.
565 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2026.

Based on denkapparat Operations's 13F filing for Q2 2026, filed 6 Aug 2026.